Emergent Stability Testing for Hiv Adenoviral Tender - 139523322

Procurement Summary

Country: USA

Summary: Emergent Stability Testing for Hiv Adenoviral Vaccine Candidates

Deadline: 23 Apr 2026

Posting Date: 15 Apr 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 139523322

Document Ref. No.: NOI-NIAID-26-0001

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Document Type: Notice of Intent to Sole Source
Solicitation Number: NOI-NIAID-26-0001
Posted Date: 04/13/2026
Response Date: 04/23/2026, 12:00 PM EST
Set Aside: N/A
NAICS Code: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Product Service Code: Q301 - MEDICAL - LABORATORY TESTING
Contracting Office Address:
Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases, 5601 Fishers Lane, Rockville, MD 20852
Title: Emergent Stability Testing for HIV Adenoviral Vaccine Candidates
Description:
THIS IS A NOTICE OF INTENT AND NOT A REQUEST FOR QUOTATIONS
This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This is a Notice of Intent to award a sole source, firm-fixed price purchase order under the authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 13.106-1(b)(2) and 13.501(a) - Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements and is not a request for competitive proposals.
The National Institute of Allergy and Infectious Diseases (NIAID), Division of AIDS (DAIDS) intends to negotiate on a sole source basis with Emergent Travel Health Inc., 555 Twin Dolphin Dr, Ste 360, Redwood City, CA 94065-2142. This acquisition will provide maintenance of the Biologics Master File 018816 - Human Immunodeficiency Virus Type 1, Recombinant (Adenovirus Type 4; Ad4Env150KN and Ad4-Env145FL; 1086 clade C Env; A549 Cells) Vaccines, Live Master File (BB-MF 018816).
BB-MF 018816 was originally established by Emergent under Purchase Order 75N93022PO1224 and contains CMC and nonclinical study information for the HIV-1 Adenovirus Type 4-Vectored (A549 cells) Vaccines, Live, Aqueous (Ad4-HIV). Purchase Order 75N93022PO1224 ended with stability work being transitioned to a testing lab contracte...
Notice ID: noi-niaid-26-0001

Department/Ind. Agency: health and human services, department of

Sub-tier: national institutes of health

Office: national institute of health nih-od

Product Service Code: q301 - reference laboratory testing

NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Inactive Dates: may 08, 2026

Inactive Policy: 15 days after response date

Documents

 Tender Notice